Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,976 | 7,389 | 6,071 | 4,816 | 13,734 |
| Marketable Securities | 6,741 | 10,825 | 17,859 | 31,076 | 30,998 |
| Receivables | 178 | N/A | 38 | N/A | 7 |
| TOTAL | $13,695 | $19,054 | $25,596 | $38,527 | $47,653 |
| Non-Current Assets | |||||
| PPE Net | 38 | 44 | 51 | 59 | 69 |
| Intangibles | 0 | 0 | 0 | 432 | 861 |
| Other Non-Current Assets | 441 | 527 | 612 | 710 | 2,438 |
| TOTAL | $479 | $571 | $663 | $1,201 | $3,368 |
| Total Assets | $14,174 | $19,625 | $26,259 | $39,728 | $51,021 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 12,203 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 822 | 2,966 | 4,996 | 5,514 | 3,715 |
| Accrued Expenses | 2,260 | 1,859 | 7,761 | 9,049 | 5,171 |
| Other current liabilities | 13,693 | 755 | 761 | 1,787 | 1,943 |
| TOTAL | $16,775 | $17,794 | $13,518 | $16,396 | $10,829 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 11,453 | 12,462 | 11,666 |
| Other Non-Current Liabilities | 8,312 | 7,981 | 7,691 | 7,438 | 21,397 |
| TOTAL | $8,312 | $7,981 | $19,144 | $19,900 | $33,063 |
| Total Liabilities | $25,087 | $25,775 | $32,662 | $36,296 | $43,892 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,706 | 16,555 | 16,427 | 13,050 | 13,041 |
| Common Shares | 166 | 165 | 135 | 130 | 130 |
| Retained earnings | -473,396 | -468,399 | -461,298 | -448,936 | -445,059 |
| Other shareholders' equity | -1 | 0 | 1 | 3 | -26 |
| TOTAL | $-10,913 | $-6,150 | $-6,403 | $3,432 | $7,129 |
| Total Liabilities And Equity | $14,174 | $19,625 | $26,259 | $39,728 | $51,021 |